The Oklahoma Shared Clinical and Translational Resources

The OSCTR is funded by the National Institutes of Health as part of its IDeA-CTR program. We have the mission to serve as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Clinical and Translational Science Institute

 

OCTSI is the home of the OSCTR, as well as clinical research services and dissemination and implementation resources to help improve the delivery of healthcare. 

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

Presbyterian Health Foundation Seed and Bridge Grants

Presbyterian Health Foundation has graciously agreed to provide significant funds for seed and bridge grants for OUHC faculty members. 

ELIGIBILITY: Limited to OUHC faculty

DEADLINE: June 27, 2014 with an anticipated start date of October 1, 2014. 

Details about the program scope, submission process, eligibility, application guidelines and funding information are found in the attached announcements.

Seed grants

OUHC/UNMHSC Collaborative Pilot Grants RFP

The Clinical and Translational Science Award (CTSA) of the University of New Mexico Health Sciences Center (UNM HSC) and the Oklahoma Shared Clinical and Translational Resources (OSCTR) of the University of Oklahoma Health Campus (OUHC) are soliciting applications from all faculty members—senior as well as junior investigators—for pilot projects that will exemplify the CTSA/IDeA-CTR mission of developing clinical and translational research, to promote and support the “bench to bedside to community and practice and back” goal of the National Institutes of Health.

Subscribe to News

Recent Publications

Enhancing geriatric trauma mortality prediction: Modifying and assessing the Geriatric Trauma Outcome Score with net benefit and decision curve analysis

Acad Emerg Med. 2025 Feb 6. doi: 10.1111/acem.15103. Online ahead of print.

ABSTRACT

OBJECTIVE: Calibration and discrimination indicators alone are insufficient for evaluating the clinical usefulness of prediction models, as they do not account for the cost of misclassification errors. This study aimed to modify the Geriatric Trauma Outcome Score (GTOS) and assess the clinical utility of the modified model using net benefit (NB) and decision curve analysis (DCA) for predicting in-hospital mortality.

Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe COVID-19: An Analysis of the National COVID Cohort Collaborative (N3C)

Pharmacoepidemiol Drug Saf. 2024 Aug;33(8):e5869. doi: 10.1002/pds.5869.

ABSTRACT

PURPOSE: Paxlovid is effective in reducing COVID-19 hospitalization and mortality. This study characterized Paxlovid use and evaluated outcomes over time among community-dwelling adults at high risk of progression to severe COVID-19 disease.

Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants

J Rural Health. 2024 Jul 2. doi: 10.1111/jrh.12857. Online ahead of print.

ABSTRACT

PURPOSE: To investigate the enduring challenges in adverse COVID-19 events between urban and rural communities in the United States, focusing on the effects of SARS-CoV-2 vaccination and therapeutic advances on patient outcomes.

Media